Drug screening identifies tazarotene and bexarotene as therapeutic agents in Multiple Sulfatase Deficiency II

ABSTRACT: We analysed differences in gene expression upon treatment of MSD patient fibroblast lines and control fibroblast lines with tazarotene and bexarotene or DMSO control (untreated condition)

ORGANISM(S): Homo sapiens

PROVIDER: GSE205556 | GEO | 2022/10/31

REPOSITORIES: GEO